Literature DB >> 25620098

A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease

Ondrej Benek, Laura Aitken, Lukas Hroch, Kamil Kuca, Frank Gunn-Moore, Kamil Musilek1.   

Abstract

The amyloid-β peptide (Aβ) has been associated with Alzheimer's disease (AD) for decades. The original amyloid cascade hypothesis declared that the insoluble extracellular plaques were responsible for Aβ toxicity. Later, this hypothesis has been updated and soluble intracellular Aβ forms and their effects within the cell have come into focus.Mitochondrial dysfunction plays an important role in the pathophysiology of AD. Aβ was detected inside mitochondria and several mitochondrial proteins were found to interact directly with Aβ. Such interactionscan affecta protein's function and cause damage to the mitochondria and finally to the whole cell.This review summarizes the current knowledge of mitochondrial proteins directly interacting with Aβ and discusses their significance for the development of therapeutics in the treatment of AD.

Entities:  

Year:  2015        PMID: 25620098     DOI: 10.2174/0929867322666150114163051

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  13 in total

Review 1.  Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases.

Authors:  Maria Valeria Catani; Valeria Gasperi; Tiziana Bisogno; Mauro Maccarrone
Journal:  Antioxid Redox Signal       Date:  2017-07-24       Impact factor: 8.401

2.  Aβ25-35 Suppresses Mitochondrial Biogenesis in Primary Hippocampal Neurons.

Authors:  Weiguo Dong; Feng Wang; Wanqing Guo; Xuehua Zheng; Yue Chen; Wenguang Zhang; Hong Shi
Journal:  Cell Mol Neurobiol       Date:  2015-06-09       Impact factor: 5.046

3.  The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.

Authors:  Angela Smilansky; Liron Dangoor; Itay Nakdimon; Danya Ben-Hail; Dario Mizrachi; Varda Shoshan-Barmatz
Journal:  J Biol Chem       Date:  2015-11-05       Impact factor: 5.157

4.  AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons.

Authors:  Feng-Li Zhao; Fang Fang; Pei-feng Qiao; Ning Yan; Dan Gao; Yong Yan
Journal:  Oxid Med Cell Longev       Date:  2016-01-31       Impact factor: 6.543

Review 5.  Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration.

Authors:  Rona R Ramsay; Magdalena Majekova; Milagros Medina; Massimo Valoti
Journal:  Front Neurosci       Date:  2016-08-22       Impact factor: 4.677

Review 6.  Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.

Authors:  Varda Shoshan-Barmatz; Yakov Krelin; Anna Shteinfer-Kuzmine; Tasleem Arif
Journal:  Front Oncol       Date:  2017-07-31       Impact factor: 6.244

Review 7.  T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers.

Authors:  Anna Mietelska-Porowska; Urszula Wojda
Journal:  J Immunol Res       Date:  2017-02-15       Impact factor: 4.818

8.  Cross-Species Analysis of Gene Expression and Function in Prefrontal Cortex, Hippocampus and Striatum.

Authors:  Wei Chen; Xiayu Xia; Nan Song; Ying Wang; Hua Zhu; Wei Deng; Qi Kong; Xianmin Pan; Chuan Qin
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

9.  VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress.

Authors:  Varda Shoshan-Barmatz; Eduardo N Maldonado; Yakov Krelin
Journal:  Cell Stress       Date:  2017-10-01

10.  Dietary Tocotrienol/γ-Cyclodextrin Complex Increases Mitochondrial Membrane Potential and ATP Concentrations in the Brains of Aged Mice.

Authors:  Anke Schloesser; Tuba Esatbeyoglu; Stefanie Piegholdt; Janina Dose; Naoko Ikuta; Hinako Okamoto; Yoshiyuki Ishida; Keiji Terao; Seiichi Matsugo; Gerald Rimbach
Journal:  Oxid Med Cell Longev       Date:  2015-08-02       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.